BIO (BioProtocol) fluctuates 41.0% in 24 hours: Driven by PEPTAIIgnitionSale oversubscription and trading volume surge
Bitget Pulse2026/05/02 13:35Volatility Brief
In the past 24 hours, BIO price rebounded from a low of $0.03964 to a high of $0.05590, currently trading at $0.05561, with an overall price swing of 41.0%. Trading volume has surged significantly, with a 24-hour turnover exceeding $45 million, at times reaching 25 times the average level; Open Interest (OI) has spiked 43.8%, and the funding rate has turned negative to -0.023%, indicating increasing pressure on shorts.
Brief Analysis of the Move
• Bio Protocol officially launched the PEPTAI Ignition Sale (AI agent project for peptide drugs), exceeding 5.9 times the subscription in just 30 minutes after going live, 20% of the supply was allocated to BIO stakers, incentivizing staking and USDC participation, thus driving active trading.
• Trading volume soared 207%, led by buying momentum (196K USDT within 15 minutes), with open interest rising in tandem. The negative funding rate intensified the short squeeze, resulting in a rapid price surge.
• The DeSci sector rotation has accelerated, while market attention grew due to the upgrade of BioXP and listing rumors on Upbit Korea, pushing turnover up to the $300 million level.
Market View and Outlook
The prevailing community sentiment is bullish, with long positions dominating on X, viewing the current situation as an opportunity for DeSci+AI biotech sector rotation. The target price is $0.048-$0.055, but the risk of a short-term squeeze is high (RSI at 78, indicating overbought conditions); analysts advise caution regarding a potential pullback to the $0.032-$0.037 support zone, and recommend monitoring the progress of the PEPTAI sale and staking data. If the price holds above $0.041, it is advised to maintain long positions.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for information purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Treasury "Extreme Short Sellers" Gather! With Oil Prices and Treasury Yields "Dual Pressure," Rate Hike Expectations Surge, Market Bets Real Money on a New Round of Tightening
According to some veteran Wall Street analysts, the most favorable combination for the market is a small rate hike accompanied by a clear data-dependent stance, allowing investors to interpret it as a limited and moderate monetary policy adjustment to guard against recurring inflation.
Intel CEO: CPU only meets 50% of demand, 14A to start production in Q1 next year, new architecture may reduce inference power consumption to 1/15 of GPU
Intel CEO Pat Gelsinger stated that the era of AI agents has triggered an explosion in CPU demand, and Intel is currently able to meet only about 50% of its customers' supply needs, with several tech giant CEOs calling to secure supply. In terms of manufacturing process, the 18A node is now in full mass production, while the 14A node will begin production in the first quarter of next year. By opening up factory data, yield rates are improving by about 7% annually. Additionally, he is advancing neuromorphic computing to address energy consumption bottlenecks and expects quantum computing to have a substantial industrial impact within 3 to 5 years.
